文献速递消化道肿瘤放疗放疗物理与技术姑息放疗与转移瘤

胰腺癌立体定向磁共振引导自适应放疗的快速稳健在线计划策略

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
PubMed 文献 · Radiother Oncol · 2017-08-12

该研究在局部晚期胰腺癌中实施基于MRIdian系统的立体定向磁共振引导自适应放疗在线计划调整策略,采用距PTV表面3cm范围内OAR再勾画和基于人工神经网络(ANN)的OAR剂量稳健预测进行在线再优化。对比50个既往治疗分次发现,SMART3CM策略所需优化次数显著少于全尺度OAR再勾画方法(平均4次 vs 18次),PTV覆盖一致(平均V95%=89%),且SMART3CM自适应计划对OAR的中高剂量显著更低,而FULLOAR在36%的病例中未能满足V33Gy剂量约束。

要点

  • SMART3CM仅需距PTV表面3cm内OAR再勾画,平均4次优化即可满足所有目标和OAR约束。
  • SMART3CM与FULLOAR的PTV覆盖一致,平均V95%均为89%。
  • SMART3CM自适应计划对OAR中高剂量显著低于FULLOAR,FULLOAR有36%病例未达V33Gy约束。

核心结论

  • SMART3CM策略用于局部晚期胰腺癌可实现良好的OAR保护与足够的靶区覆盖,同时仅需临床医生有限的在线再勾画。

研究设计与样本

  • 在MRIdian系统上实施SMART在线计划调整策略,采用距PTV表面3cm内OAR再勾画和基于ANN的OAR剂量稳健预测进行在线再优化。
  • 通过比较50个既往治疗分次,评估SMART3CM与全尺度OAR再勾画(FULLOAR)标准再计划方法。

主要发现

  • SMART3CM达到所有目标和机构OAR约束所需优化次数显著低于FULLOAR(平均4次 vs 18次)。
  • 两种策略的PTV覆盖相同,平均V95%=89%。
  • SMART3CM自适应计划对所有OAR的中高剂量显著低于FULLOAR。
  • FULLOAR在36%的病例中未能遵守V33Gy剂量约束。

关键数值与推荐

  • 计划质量评估采用PTV覆盖指标(V95%、Dmean、D1cc)和机构OAR约束(如V33Gy)。

临床怎么用

  • 局部晚期胰腺癌SMART可仅对距PTV表面3cm内OAR进行在线再勾画,结合ANN剂量预测快速生成满足约束的自适应计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To implement a robust and fast stereotactic MR-guided adaptive radiation therapy (SMART) online strategy in locally advanced pancreatic cancer (LAPC). MATERIAL AND METHODS: SMART strategy for plan adaptation was implemented with the MRIdian system (ViewRay Inc.). At each fraction, OAR (re-)contouring is done within a distance of 3cm from the PTV surface. Online plan re-optimization is based on robust prediction of OAR dose and optimization objectives, obtained by building an artificial neural network (ANN). Proposed limited re-contouring strategy for plan adaptation (SMART3CM) is evaluated by comparing 50 previously delivered fractions against a standard (re-)planning method using full-scale OAR (re-)contouring (FULLOAR). Plan quality was assessed using PTV coverage (V95%, Dmean, D1cc) and institutional OAR constraints (e.g. V33Gy). RESULTS: SMART3CM required a significant lower number of optimizations than FULLOAR (4 vs 18 on average) to generate a plan meeting all objectives and institutional OAR constraints. PTV coverage with both strategies was identical (mean V95%=89%). Adaptive plans with SMART3CM exhibited significant lower intermediate and high doses to all OARs than FULLOAR, which also failed in 36% of the cases to adhere to the V33Gy dose constraint. CONCLUSIONS: SMART3CM approach for LAPC allows good OAR sparing and adequate target coverage while requiring only limited online (re-)contouring from clinicians.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Bohoudi O, Bruynzeel AME, Senan S, et al. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Radiother Oncol. 2017. PMID: 28811038. doi:10.1016/j.radonc.2017.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。